In the active control
group, an increasing proportion of patients had emesis
or needed to use rescue medication 9–12 h after
initiation of chemotherapy and throughout the at-risk
period. At about 48 h in HEC-1 and 72 h in HEC-2, the
rolapitant curve began to plateau,